Dermapharm Holding SE
DMP | F
Overview
Corporate Details
- ISIN(s):
- DE000A2GS5D8
- LEI:
- 5299009F0KNZINQQQK37
- Country:
- Germany
- Address:
- Lil-Dagover-Ring 7, 82031 Grünwald
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States. In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Dermapharm Holding SE.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 07:30 |
Earnings Release
Dermapharm Holding SE remains on projected growth trajectory in Q2 2025
|
English | 15.1 KB | |
| 2025-07-04 16:18 |
Director's Dealing
Dermapharm Holding SE: Wilhelm Beier, buy
|
English | 5.8 KB | |
| 2025-07-01 12:30 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 12.3 KB | |
| 2025-06-27 14:40 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.0 KB | |
| 2025-06-26 17:43 |
Post-Annual General Meeting Information
Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of…
|
English | 10.9 KB | |
| 2025-06-24 16:46 |
Director's Dealing
Dermapharm Holding SE: Dr. Andreas Eberhorn, buy
|
English | 5.8 KB | |
| 2025-06-05 12:29 |
Director's Dealing
Dermapharm Holding SE: Anja Schorn, buy
|
English | 6.2 KB | |
| 2025-06-04 11:19 |
Director's Dealing
Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy
|
English | 6.9 KB | |
| 2025-05-16 15:05 |
Pre-Annual General Meeting Information
Dermapharm Holding SE: Bekanntmachung der Einberufung zur Hauptversammlung am 2…
|
German | 59.4 KB | |
| 2025-05-15 07:30 |
Earnings Release
Dermapharm Holding SE performs in line with projections in Q1 2025, confirms fu…
|
English | 23.6 KB | |
| 2025-05-15 00:00 |
Interim Report
Q1 statement / Q1 financial report 2025
|
English | 347.5 KB | |
| 2025-05-07 08:40 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2025-04-14 15:08 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 12.1 KB | |
| 2025-04-08 16:44 |
Director's Dealing
Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy
|
English | 6.4 KB | |
| 2025-03-28 07:30 |
Earnings Release
Successful financial year 2024: Dermapharm increases revenue and exceeds EBITDA…
|
English | 26.5 KB |
Automate Your Workflow. Get a real-time feed of all Dermapharm Holding SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Dermapharm Holding SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-30 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 54,530,000.00 EUR |
| 2024-12-30 | Beier, Wilhelm | Supervisory board | Buy | None | 3,895,000.00 EUR |
| 2024-11-15 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 6,464,000.00 EUR |
| 2024-11-11 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 95,185.00 EUR |
| 2024-11-05 | Dreibholz, Christof | Board | Buy | None | 27,720.00 EUR |
| 2024-10-23 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 19,704.55 EUR |
| 2024-08-29 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 29,954,600.00 EUR |
| 2024-06-11 | Lanz, Susanne Gertrud Pia | Close relation | Buy | None | 101,778.57 EUR |
| 2024-05-22 | Themis Beteiligungs-Aktiengesellschaft | Close relation | Buy | None | 8,577,500.00 EUR |
| 2023-06-27 | Feldmeier, Dr. Hans-Georg | Board | Buy | None | 99,902.36 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
| TORII PHARMACEUTICAL CO., LTD. | Japan | 4551 | ||
|
TOWA PHARMACEUTICAL CO.,LTD. | Japan | 4553 | |
|
TSUMURA & CO. | Japan | 4540 | |
|
TURK İLAÇ VE SERUM SANAYİ A.Ş. | Türkiye | TRILC | |
|
UCB | Belgium | UCB | |
|
Valneva SE | France | VLA | |
|
VENTURE LIFE GROUP PLC | United Kingdom | VLG | |
|
Vetoquinol SA | France | VETO | |
|
Vicore Pharma Holding | Sweden | VICO | |
|
Vifor Pharma AG | Switzerland | VIFN |